参考文献/References:
[1] KAN H S,CHAN P K,CHIU K Y,et al.Non-surgical treatment of knee osteoarthritis[J].Hong Kong Med J,2019,25(2):127-133.
[2] HUNTER D J,BIERMA-ZEINSTRA S.Osteoarthritis[J].Lancet,2019,393(10182):1745-1759.
[3] JANG S,LEE K,JU J H.Recent updates of diagnosis,pathophysiology,and treatment on osteoarthritis of the knee[J].Int J Mol Sci,2021,22(5):2619.
[4] GIORGINO R,ALBANO D,FUSCO S,et al.Knee osteoarthritis:epidemiology,pathogenesis,and mesenchymal stem cells:What else is new?An update[J].Int J Mol Sci,2023,24(7):6405.
[5] SCHJERNING A M,MCGETTIGAN P,GISLASON G.Cardiovascular effects and safety of(non-aspirin)NSAIDs[J].Nat Rev Cardiol,2020,17(9):574-584.
[6] DOMPER A M,HIJOS-MALLADA G,LANAS A.Gastrointestinal and cardiovascular adverse events associated with NSAIDs[J].Expert Opin Drug Saf,2022,21(3):373-384.
[7] 陆嘉柯,陈佳俊,张小宁,等.从肝论治膝骨性关节炎研究进展[J].浙江中医杂志,2022,57(1):74-75.
[8] 高慧,许朝霞,王庆盛,等.概述不同年龄阶段人群的中医体质及证候特征研究进展[J].世界科学技术-中医药现代化,2021,23(2):495-499.
[9] 何帮靖,周明旺,李盛华,等.李盛华教授从“虚、痰、瘀、毒”论治膝骨关节炎的思路探析[J].时珍国医国药,2022,33(11):2784-2786.
[10] 欧梁,卢敏,张永辉,等.基于“虚、瘀、毒”病机理论的膝痹病病证结合模型的建立及评价[J].中国实验动物学报,2023,31(5):590-597.
[11] 谭旭仪,邝高艳,卢敏.膝骨关节炎的“虚、瘀、毒”病机特点探析[J].中国实验方剂学杂志,2018,24(24):201-206.
[12] 邝高艳,严可,卢敏,等.从毒瘀论治膝骨关节炎及毒瘀本质的分析[J].辽宁中医杂志,2019,46(3):492-494.
[13] 张世臣,徐文娟,孙静,等.本草经典理论体系之毒理论[J].中国现代中药,2023,25(10):2213-2220.
[14] 芮红丽,张念志.基于“痰瘀”理论探讨虫类药在间质性肺病的应用[J].中医临床研究,2022,14(32):88-91.